Skip to main navigation Skip to search Skip to main content

One-Carbon Metabolism and Chemotherapy-induced Toxicities in Patients with Stage II-III Colorectal Cancer: A Prospective Cohort Study

  • Nienke R.K. Zwart*
  • , Fränzel J.B. van Duijnhoven
  • , Evertine Wesselink
  • , Floor J.E. Lubberman
  • , Cornelia M. Ulrich
  • , Jill A. McKay
  • , Henk K. van Halteren
  • , Adrian McCann
  • , Per Magne Ueland
  • , Ellen Kampman
  • , Dieuwertje E. Kok
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)
6 Downloads (Pure)

Abstract

Introduction
One-carbon metabolism (OCM) is a target of the chemotherapeutic agent capecitabine. We investigated OCM biomarker concentrations in relation to capecitabine-induced toxicities in patients with stage II-III colorectal cancer (CRC).

Method
Within a prospective cohort, 297 patients receiving adjuvant capecitabine-based chemotherapy were included. Pretreatment plasma concentrations of the OCM biomarkers folate, vitamin B2, vitamin B6, vitamin B12, total homocysteine, methionine, serine, and glycine were determined. We also investigated whether associations differed according to MTHFR C677T genotypes. Chemotherapy-induced toxicities were defined as toxicity-induced modifications of capecitabine treatment. To allow for inspection of shapes of the associations, restricted cubic splines (RCS) and Cox proportional hazards models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) adjusted for age and sex.

Results
In total, 156 (53%) patients experienced toxicity-induced modifications of capecitabine treatment. Folate was not associated with toxicities in the overall population. Higher folate concentrations were associated with a lower risk of toxicities in patients with MTHFR C677T CT/TT genotype (HRperdoubling 0.75, 95%CI 0.57-0.98) but not in patients with CC genotype (HRperdoubling 1.17, 95%CI 0.84-1.63). Higher concentrations of vitamin B2 were associated with a lower risk of toxicities (HRperdoubling 0.81 95%CI 0.67-0.99), whereas higher glycine concentrations were associated with a higher risk of toxicities (HRperdoubling 1.87, 95%CI 1.18-2.94). The association between vitamin B6 and vitamin B12 and toxicities appeared nonlinear. Homocysteine, methionine, and serine were not associated with toxicities.

Conclusions
Future studies investigating whether nutrition-guided optimization of OCM biomarkers will result in improved treatment tolerance are warranted.
Original languageEnglish
Article number101457
Number of pages11
JournalAmerican Journal of Clinical Nutrition
Volume124
Issue number3
Early online date27 Jul 2026
DOIs
Publication statusPublished - 1 Sept 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • one-carbon metabolism
  • B-vitamins
  • colorectal cancer
  • chemotherapy
  • toxicity

Fingerprint

Dive into the research topics of 'One-Carbon Metabolism and Chemotherapy-induced Toxicities in Patients with Stage II-III Colorectal Cancer: A Prospective Cohort Study'. Together they form a unique fingerprint.

Cite this